Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6,903 | 7,237 | 7,114 | 7,696 | 8,038 | 8,381 | 8,528 | 8,572 | 8,828 | 8,753 | 7,546 | 8,100 | |
| COGS | 2,003 | 2,176 | 2,092 | 2,182 | 2,367 | 2,582 | 2,850 | 2,808 | 3,124 | 3,095 | 3,213 | 3,385 |
| Gross profit | 4,900 | 5,061 | 5,022 | 5,514 | 5,672 | 5,800 | 5,678 | 5,765 | 5,705 | 5,658 | 4,334 | 4,715 |
| 2,887 | 3,035 | 3,187 | 3,379 | 3,589 | 3,523 | 3,675 | 3,591 | 3,688 | 3,768 | 3,947 | 3,854 | |
| 2,013 | 2,026 | 1,835 | 2,136 | 2,083 | 2,277 | 2,003 | 2,174 | 2,016 | 1,890 | 387 | 861 | |
| OPM % | 29.2% | 28% | 25.8% | 27.8% | 25.9% | 27.2% | 23.5% | 25.4% | 22.8% | 21.6% | 5.1% | 10.6% |
| Depreciation | 376 | 374 | 368 | 381 | 397 | 471 | 455 | 476 | 505 | 521 | 557 | 537 |
| Interest | 35 | 39 | 59 | 60 | 76 | 82 | 66 | 83 | 91 | 94 | 106 | 126 |
| 315 | 216 | 198 | 187 | 308 | 150 | 522 | 290 | 324 | 269 | 475 | 355 | |
| Profit before tax | 1,917 | 1,829 | 1,605 | 1,883 | 1,917 | 1,874 | 2,005 | 1,905 | 1,745 | 1,543 | 200 | 553 |
| Tax | 435 | 448 | 295 | 490 | 576 | 470 | 419 | 495 | 408 | 354 | -22 | 118 |
| Tax % | 22.7% | 24.5% | 18.4% | 26% | 30% | 25.1% | 20.9% | 26% | 23.4% | 22.9% | -10.8% | 21.3% |
| 1,482 | 1,381 | 1,310 | 1,392 | 1,342 | 1,404 | 1,587 | 1,410 | 1,337 | 1,190 | 221 | 436 | |
| PAT margin % | 21.5% | 19.1% | 18.4% | 18.1% | 16.7% | 16.8% | 18.6% | 16.5% | 15.1% | 13.6% | 2.9% | 5.4% |
| EPS (₹) | 89.1 | 82.9 | 78.7 | 83.6 | 15.1 | 17 | 19.1 | 17 | 16.2 | 14.5 | 2.7 | 5.3 |
| Results filing | — | — | — | — | — | — | Results filing for Mar 2025 | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +9% | +6.6% | +12.6% | +13.9% | +16.5% | +15.8% | +19.9% | +11.4% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Global Generics | 7,208.3 | 3,712.7 | 0 | 0 |
| Pharmaceutical Services and Active Ingredients | 1,073 | 38.6 | 0 | 0 |
| Others | 19.3 |
| +9.8% |
| +4.4% |
| -11.5% |
| -5.5% |
| PAT YoY % | +33% | +11% | +36.4% | -0.9% | -9.5% | +1.7% | +21.1% | +1.3% | -0.4% | -15.3% | -86.1% | -69.1% |
| 3.6 |
| 0 |
| 0 |
₹ crore by quarter